{"success":true,"data":{"pressRelease":{"id":"171939","rtpr_id":"nPn6QdqKna-20261017","ticker":"HIMS","exchange":"NYSE","all_tickers":["HIMS"],"title":"HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit","author":"PR Newswire","published_at":"2026-10-17T21:43:00.052Z","article_body":"HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit\nPR Newswire\n\nNEW YORK, Oct. 17, 2026\n\nNEW YORK, Oct. 17, 2026 /PRNewswire/ --\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of\nsecurities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4,\n2025 and July 29, 2026, both dates inclusive (the \"Class Period\"), of the\nimportant November 2, 2026 lead plaintiff deadline.\n\nSo what: If you purchased Hims securities during the Class Period you may be\nentitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWhat to do next: To join the Hims class action, go to\nhttps://rosenlegal.com/cases/hims-hers-health-inc/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=2974078810&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than November 2,\n2026. A lead plaintiff is a representative party acting on behalf of other\nclass members in directing the litigation.\n\nWhy Rosen Law: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer\nrecognition. Many of these firms do not actually handle securities class\nactions, but are merely middlemen that refer clients or partner with law firms\nthat actually litigate the cases. Be wise in selecting counsel. The Rosen Law\nFirm represents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved the largest ever securities class action settlement against a\nChinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class\nAction Services for number of securities class action settlements in 2017. The\nfirm has been ranked in the top 4 each year since 2013 and has recovered\nbillions of dollars for investors. In 2019 alone the firm secured over $438\nmillion for investors. In 2020, founding partner Laurence Rosen was named by\nlaw360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been\nrecognized by Lawdragon and Super Lawyers.\n\nDetails of the case: According to the lawsuit, throughout the Class Period,\ndefendants made materially false and misleading statements and/or failed to\ndisclose that: (1) Hims shared consumers' health information with third-party\nadvertising platforms; (2) Hims charges consumers for prescriptions almost\nimmediately after they submit an intake form, despite telling consumers that\nthey will be able to consult with a medical provider to find a treatment that\nis \"right for them;\" (3) the foregoing conduct subjected Hims to regulatory\nscrutiny; (4) as a result of the foregoing, Hims was reasonably likely to\nincur fees and penalties; and (5) as a result of the foregoing, defendants'\npositive statements about Hims' business, operations, and prospects were\nmaterially misleading and/or lacked a reasonable basis. When the true details\nentered the market, the lawsuit claims that investors suffered damages.\n\nTo join the Hims class action, go to\nhttps://rosenlegal.com/cases/hims-hers-health-inc/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=2974078810&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=1007062319&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm)\n, on Twitter: https://twitter.com/rosen_firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=107136891&u=https%3A%2F%2Ftwitter.com%2Frosen_firm&a=https%3A%2F%2Ftwitter.com%2Frosen_firm)\n or on Facebook: https://www.facebook.com/rosenlawfirm/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=4133473878&u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F)\n.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\n\n     Laurence Rosen, Esq.\n     Phillip Kim, Esq.\n     The Rosen Law Firm, P.A.\n     275 Madison Avenue, 40th Floor\n     New York, NY 10016\n     Tel: (212) 686-1060\n     Toll Free: (866) 767-3653\n     Fax: (212) 202-3827\n     case@rosenlegal.com (mailto:case@rosenlegal.com)\n     www.rosenlegal.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=1803985079&u=http%3A%2F%2Fwww.rosenlegal.com%2F&a=www.rosenlegal.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/hims-deadline-hims-investors-have-opportunity-to-lead-hims--hers-health-inc-securities-fraud-lawsuit-302911679.html\n(https://www.prnewswire.com/news-releases/hims-deadline-hims-investors-have-opportunity-to-lead-hims--hers-health-inc-securities-fraud-lawsuit-302911679.html)\n\nSOURCE THE ROSEN LAW FIRM, P. A.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA3024730\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn6QdqKna-20261017","title":"HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit","author":"PR Newswire","ticker":"HIMS","created":"2026-10-17T21:43:00.052Z","tickers":["HIMS"],"exchange":"NYSE","article_body":"HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit\nPR Newswire\n\nNEW YORK, Oct. 17, 2026\n\nNEW YORK, Oct. 17, 2026 /PRNewswire/ --\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of\nsecurities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4,\n2025 and July 29, 2026, both dates inclusive (the \"Class Period\"), of the\nimportant November 2, 2026 lead plaintiff deadline.\n\nSo what: If you purchased Hims securities during the Class Period you may be\nentitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWhat to do next: To join the Hims class action, go to\nhttps://rosenlegal.com/cases/hims-hers-health-inc/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=2974078810&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than November 2,\n2026. A lead plaintiff is a representative party acting on behalf of other\nclass members in directing the litigation.\n\nWhy Rosen Law: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer\nrecognition. Many of these firms do not actually handle securities class\nactions, but are merely middlemen that refer clients or partner with law firms\nthat actually litigate the cases. Be wise in selecting counsel. The Rosen Law\nFirm represents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved the largest ever securities class action settlement against a\nChinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class\nAction Services for number of securities class action settlements in 2017. The\nfirm has been ranked in the top 4 each year since 2013 and has recovered\nbillions of dollars for investors. In 2019 alone the firm secured over $438\nmillion for investors. In 2020, founding partner Laurence Rosen was named by\nlaw360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been\nrecognized by Lawdragon and Super Lawyers.\n\nDetails of the case: According to the lawsuit, throughout the Class Period,\ndefendants made materially false and misleading statements and/or failed to\ndisclose that: (1) Hims shared consumers' health information with third-party\nadvertising platforms; (2) Hims charges consumers for prescriptions almost\nimmediately after they submit an intake form, despite telling consumers that\nthey will be able to consult with a medical provider to find a treatment that\nis \"right for them;\" (3) the foregoing conduct subjected Hims to regulatory\nscrutiny; (4) as a result of the foregoing, Hims was reasonably likely to\nincur fees and penalties; and (5) as a result of the foregoing, defendants'\npositive statements about Hims' business, operations, and prospects were\nmaterially misleading and/or lacked a reasonable basis. When the true details\nentered the market, the lawsuit claims that investors suffered damages.\n\nTo join the Hims class action, go to\nhttps://rosenlegal.com/cases/hims-hers-health-inc/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=2974078810&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fhims-hers-health-inc%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=1007062319&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm)\n, on Twitter: https://twitter.com/rosen_firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=107136891&u=https%3A%2F%2Ftwitter.com%2Frosen_firm&a=https%3A%2F%2Ftwitter.com%2Frosen_firm)\n or on Facebook: https://www.facebook.com/rosenlawfirm/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=4133473878&u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F)\n.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\n\n     Laurence Rosen, Esq.\n     Phillip Kim, Esq.\n     The Rosen Law Firm, P.A.\n     275 Madison Avenue, 40th Floor\n     New York, NY 10016\n     Tel: (212) 686-1060\n     Toll Free: (866) 767-3653\n     Fax: (212) 202-3827\n     case@rosenlegal.com (mailto:case@rosenlegal.com)\n     www.rosenlegal.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4800251-1&h=1803985079&u=http%3A%2F%2Fwww.rosenlegal.com%2F&a=www.rosenlegal.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/hims-deadline-hims-investors-have-opportunity-to-lead-hims--hers-health-inc-securities-fraud-lawsuit-302911679.html\n(https://www.prnewswire.com/news-releases/hims-deadline-hims-investors-have-opportunity-to-lead-hims--hers-health-inc-securities-fraud-lawsuit-302911679.html)\n\nSOURCE THE ROSEN LAW FIRM, P. A.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA3024730\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-17T21:43:00.114439903Z","server_sent_at_ms":1792273380114},"received_at":"2026-10-17T21:43:00.165Z","source_url":"https://www.prnewswire.com/news-releases/hims-deadline-hims-investors-have-opportunity-to-lead-hims--hers-health-inc-securities-fraud-lawsuit-302911679.html"},"analysis":{"id":"160087","press_release_id":"171939","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":["securities fraud class action alleges undisclosed sharing of consumer health data with third-party ad platforms and immediate prescription billing","alleged regulatory scrutiny and potential fees/penalties remain an overhang for HIMS"],"eventType":"legal_litigation","narrative":"Rosen Law Firm issued a shareholder-solicitation notice for Hims & Hers Health (HIMS), reminding purchasers between August 4, 2025 and July 29, 2026 of the November 2, 2026 lead plaintiff deadline.\n\nThe securities fraud suit alleges HIMS shared consumer health data with ad platforms and billed consumers for prescriptions immediately after intake, creating regulatory exposure.\n\nNo class has been certified and no new issuer disclosure was made; this is law-firm marketing, not company news.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation on known allegations -- suppress."},"keyFigures":{},"quotedText":"reminds purchasers of\nsecurities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4,\n2025 and July 29, 2026, both dates inclusive (the \"Class Period\"), of the\nimportant November 2, 2026 lead plaintiff deadline.","namedEntities":{"people":[{"name":"Laurence Rosen","role":"founding partner, Rosen Law Firm"},{"name":"Phillip Kim","role":"attorney, Rosen Law Firm"}],"products":[],"companies":[{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"class action defendant / target of solicitation"},{"name":"Rosen Law Firm","relationship":"plaintiff law firm issuing solicitation"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation issued by Rosen Law Firm reminding HIMS investors of a lead plaintiff deadline. No new issuer disclosure, no certified class, no settlement; the underlying allegations (data sharing, billing practices) were previously known."},"tickerRelevance":{"others":[],"primary":"HIMS"},"globalImportance":15,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap retail-favorite","eventGravity":"law-firm-solicitation","issuerAuthored":false,"retailFavoriteBoost":true}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Rosen Law Firm issued a shareholder-solicitation notice for Hims & Hers Health (HIMS), reminding purchasers between August 4, 2025 and July 29, 2026 of the November 2, 2026 lead plaintiff deadline.\n\nThe securities fraud suit alleges HIMS shared consumer health data with ad platforms and billed consumers for prescriptions immediately after intake, creating regulatory exposure.\n\nNo class has been certified and no new issuer disclosure was made; this is law-firm marketing, not company news.","key_figures":{},"named_entities":{"people":[{"name":"Laurence Rosen","role":"founding partner, Rosen Law Firm"},{"name":"Phillip Kim","role":"attorney, Rosen Law Firm"}],"products":[],"companies":[{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"class action defendant / target of solicitation"},{"name":"Rosen Law Firm","relationship":"plaintiff law firm issuing solicitation"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-17T21:43:05.331Z","global_importance":15,"audience_relevance":25,"importance_components":{"tickerTier":"mid-cap retail-favorite","eventGravity":"law-firm-solicitation","issuerAuthored":false,"retailFavoriteBoost":true}},"durationMs":5153,"modelName":"glm-5.3-flashx"}}